Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.09 is 79% below its 5-year average of 0.43, near the low end of its 5-year range (0.09–3.12).
As of the fiscal period ended Tuesday, March 31, 2026. 56.65% below its 12-month average of 0.21.
Reported quarterly current ratio; no daily interpolation. Q1 FY2026 (2026-03-31): 0.09.
CURRENT RATIO
0.09
CURRENT RATIO AVG TTM
0.21
CURRENT RATIO AVG 3Y
0.26
CURRENT RATIO AVG 5Y
0.43
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-56.65%
CURRENT VS 3Y AVG
-65.39%
CURRENT VS 5Y AVG
-79.16%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 750 covered companies
CURRENT VS SECTOR MEDIAN
-97.52%
vs the sector median at left
Market Cap
$51.13M
Current Ratio
3.74
TTM Avg
0.21
3Y Avg
0.34
5Y Avg
1.39
Market Cap
$51.35M
Current Ratio
5.31
TTM Avg
2.85
3Y Avg
8.26
5Y Avg
15.41
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celularity Inc. (CELU) | $50.80M | 0.09 | 0.21 | 0.26 | 0.43 |
| Clene Inc. (CLNN)vs › | $50.73M | 3.07 | 1.20 | 1.51 | 3.42 |
| Envoy Medical, Inc. (COCH)vs › | $50.96M | 1.73 | 0.89 | 0.86 | 0.91 |
| INmune Bio, Inc. (INMB)vs › | $50.51M | 4.04 | 3.34 | 3.69 | 7.87 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.13M | 3.74 | 0.21 | 0.34 | 1.39 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.35M | 5.31 | 2.85 | 8.26 | 15.41 |
| Microbot Medical Inc. (MBOT)vs › | $50.36M | 18.56 | 12.85 | 8.01 | 9.80 |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | 3.81 | 5.31 | 3.36 | 3.21 |
| biote Corp. (BTMD)vs › | $51.61M | 1.43 | 1.27 | 3.36 | 3.09 |
| Apollomics, Inc. (APLM)vs › | $49.85M | 0.96 | 1.17 | 2.45 | 5.02 |
Current Ratio
0.09
Quick Ratio
0.08
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-03-31 | 0.09 |
| 2025-12-31 | 0.15 |
| 2025-09-30 | 0.16 |
| 2025-06-30 | 0.25 |
| 2025-03-31 | 0.38 |
| 2024-12-31 | 0.38 |
| 2024-09-30 | 0.19 |
| 2024-06-30 | 0.26 |
| 2024-03-31 | 0.35 |
| 2023-12-31 | 0.29 |
| 2023-09-30 | 0.19 |
| 2023-06-30 | 0.28 |
| 2023-03-31 | 0.38 |
| 2022-12-31 | 0.54 |
| 2022-09-30 | 0.91 |
| 2022-06-30 | 2.29 |
| 2022-03-31 | 2.91 |
| 2021-12-31 | 2.25 |
| 2021-09-30 | 3.12 |
| 2021-06-30 | 0.75 |
| 2021-03-31 | 1.73 |
| 2020-12-31 | 2.70 |
| 2020-09-30 | 3.66 |
| 2020-06-30 | 5.34 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.78 |
| 2019-09-30 | 11.80 |
| 2019-06-30 | 7.54 |
| 2019-03-31 | 0.12 |
